Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silymarin for generalized anxiety disorder
IRCT20180201038585N13Phase 3Completed
- Sponsor
- Baqiyatallah University of Medical Sciences
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of silymarin in generalized anxiety disorder (GAD), sponsored by Baqiyatallah University of Medical Sciences. Started Feb 2025; status: completed.
02
Drugs
silymarin
03
Conditions
generalized anxiety disorder (GAD)
Beyond the preview
Go deeper on IRCT20180201038585N13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180201038585N13.